Size Exclusion Chromatography/ Mass Spectrometry Analysis of Antibody Drug Conjugates Using the Agilent 1260 Infinity II Bio-Inert LC
Applications | 2016 | Agilent TechnologiesInstrumentation
LC/TOF, LC/HRMS, LC/MS, LC/MS/MS, GPC/SEC
IndustriesPharma & Biopharma
ManufacturerAgilent Technologies
Key wordsadcs, deconvoluted, adc, trastuzumab, deglycosylated, mass, counts, drug, antibody, sec, linker, spectrum, charge, dar, conjugates, amu, buffer, lysine, mabs, assigned, characterization, entropy, cytotoxic, antibodies, linked, mab, exclusion, bio, potent, chromatography, loading, peak, using, healthy, inert, distribution, peaks, species, recombinant, trastuzamab, glycosylation, due, maytansine, arrest, binding, spectra, both, regarding, internalization, were
Similar PDF
Analysis of Antibody-Drug Conjugates Using Size Exclusion Chromatography and Mass Spectrometry
2017|Agilent Technologies|Applications
Analysis of Antibody-Drug Conjugates Using Size Exclusion Chromatography and Mass Spectrometry Application Note Biologics and Biosimilars Author Abstract Sonja Schneider Recombinant monoclonal antibodies (mAbs) have emerged as important Agilent Technologies, Inc. therapeutic agents for the treatment of different diseases. This…
Key words
trastuzumab, trastuzumabadcs, adcsadc, adcemtansine, emtansinedeconvoluted, deconvolutedcounts, countsdrug, drugdeglycosylated, deglycosylatedamu, amusec, secmass, massmabs, mabsspectrum, spectrumbuffer, bufferantibody
Improving the Quality of Antibody Drug Conjugates by Orthogonal Analytical Methods
2024|Agilent Technologies|Guides
Consumables Workflow Ordering Guide Improving the Quality of Antibody Drug Conjugates by Orthogonal Analytical Methods Antibody Drug Conjugates Antibody-drug conjugates (ADCs) represent a new generation of targeted biotherapeutics that make up a rapidly growing segment of the drug discovery pipeline.…
Key words
mylist, mylistcysteine, cysteinedar, daradc, adcadcs, adcslysine, lysinelinker, linkercolumn, columnhic, hicauristatin, auristatinvedotin, vedotinantibody, antibodymmae, mmaeintact, intactinfinitylab
A streamlined drug-to-antibody ratio determination workflow for intact and deglycosylated antibody-drug conjugates
2019|Agilent Technologies|Applications
Application Note Pharma and Biopharma A streamlined drug-to-antibody ratio determination workflow for intact and deglycosylated antibody-drug conjugates Using the Agilent AssayMAP Bravo and Agilent 6545XT AdvanceBio accurate-mass quadrupole time-of-flight LC/MS system Authors Jerry Han, Zach Van Den Heuvel, and Steve…
Key words
deglycosylation, deglycosylationaffinity, affinityassaymap, assaymapadc, adcdar, darcartridges, cartridgesadcs, adcscartridge, cartridgestreptavidin, streptavidinpurified, purifiedserum, serumantibody, antibodywere, werepurification, purificationsulfo
Routine analysis of drug to antibody ratio and drug distribution with maXis II
2020|Bruker|Applications
Routine analysis of drug to antibody ratio and drug distribution with maXis II Antibody drug conjugates (ADC) are small molecule conjugated mAbs. These are rapidly emerging complex biological molecules in the biopharma space. Abstract Characterization of ADC’s includes intact mass…
Key words
dar, daradc, adcbruker, brukermaxis, maxisdrug, drugantibody, antibodylinker, linkerconjugation, conjugationaverage, averagemab, mabdenaturing, denaturingglycoforms, glycoformsconjugated, conjugatedpotency, potencyinterchain